Acquired Activated Protein C-Resistance in Patients with Lupus Anticoagulants

• References

• 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci 1993; 90: 1004-1008
• 2 Greengard JS, Xi Su n, Xiao Xu, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1361-1362
• 3 Bertina RM, Koeleman PB C, Koster T, Rosendaal RF, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 4 Zöller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524
• 5 Hampton KK, Path MR C, Preston FE, Greaves M. Resistance to activated protein C. N Engl J Med 1994; 331: 130
• 6 Bokarewa MI, Blombäck M, Egberg N, Rosen S. A new variant of interaction between phospholipid antibodies and the protein C system. Blood Coag Fibrinolysis 1994; 5: 37-41
• 7 Thiagarajan P, Pengo V, Shapiro SS. The use of the diluted Russel viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-874
• 8 Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural pattern. Br J Haematol 1978; 40: 143-151
• 9 Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79 (06) 678-682
• 10 Triplett DA, Stocker KF, Unger GA, Bama LK. The Textarin/Ecarin Ratio: A confirmatory Test for Lupus anticoagulants. Thromb Haemost 1993; 70 (06) 925-931
• 11 Exner T, Triplett DA, Taberner D, Machin S. Guidelines for testing and revised criteria for Lupus Anticoagulants SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65 (03) 320-322
• 12 Halbmayer WM, Haushofer A, Schön R, Fischer M. Influence of lupus anticoagulant on a commercially available kit for APC resistance. Thromb Haemost 1994; 72 (04) 645-646
• 13 Schwarz HP, Varadi K, Moritz B, Lang H, Bauer K, Preston E, Peake I, Rivard GE. A chromogenic assay for activated protein C (APC) resistance. Blood 1994; 84 Suppl (Suppl. 01) 84 a
• 14 Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987; 57 (02) 144-147
• 15 Marciniak E, Romond E. Impaired catalytic function of activated protein C: A new in vitro manifestation of lupus anticoagulant. Blood 1989; 74: 2426-2432